Log in to save to my catalogue

A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocell...

A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocell...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e86d4ca4d7164edeb695ffd1f2164335

A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis

About this item

Full title

A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis

Publisher

England: BioMed Central Ltd

Journal title

BMC medicine, 2017-12, Vol.15 (1), p.214-214, Article 214

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Chronic hepatitis B virus (HBV) infection leads to liver fibrosis, which is a major risk factor in hepatocellular carcinoma (HCC) and an independent risk factor of recurrence after HCC tumor resection. The HBV genome can be inserted into the human genome, and chronic inflammation may trigger somatic mutations. However, how HBV integration and other...

Alternative Titles

Full title

A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e86d4ca4d7164edeb695ffd1f2164335

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e86d4ca4d7164edeb695ffd1f2164335

Other Identifiers

ISSN

1741-7015

E-ISSN

1741-7015

DOI

10.1186/s12916-017-0973-7

How to access this item